FDA letter monthly archive

FDA Letters Issued in March 2022

Name: FDA Letters Issued in March 2022
Creator: Assyro AI
License: https://www.usa.gov/government-works

Browse FDA application-action, complete response, and warning letters issued in March 2022. Each result links to a structured letter page with source-document access, metadata, and regulatory intelligence summaries.

CRLComplete Response Letter
Complete Response Letter Akebia Therapeutics, Inc. (Mar 29, 2022)
FDA's complete response letter contains source-text evidence related to Labeling, packaging, and proprietary name, Clinical efficacy and substantial evidence, Safety and adverse events, Statistical analysis. Theme counts identify where the letter discusses a topic; they do not replace review of the exact redacted letter.
IssuedMar 29, 2022
US FDA• VAFSEO

Complete Response Letter Akebia Therapeutics, Inc. (Mar 29, 2022)